Agilent Technologies, Inc. Announces Quarterly Dividend of $0.25 (NYSE:A)

Key Points

• Agilent Technologies has declared a quarterly dividend of $0.25 per share, which shareholders of record on September 30th will receive on October 22nd, representing an annual yield of 0.8%.
• The company reports a dividend payout ratio of 16.4%, indicating that it is well-positioned to maintain its dividend based on expected earnings of $6.08 per share next year.
• Agilent's recent quarterly earnings showed a 10.1% revenue increase year-over-year, with a revenue of $1.74 billion, and it successfully met analysts' EPS estimates at $1.37 for the quarter.

Agilent Technologies, Inc. (NYSE:A - Get Free Report) announced a quarterly dividend on Wednesday, September 17th, RTT News reports. Shareholders of record on Tuesday, September 30th will be given a dividend of 0.248 per share by the medical research company on Wednesday, October 22nd. This represents a c) annualized dividend and a yield of 0.8%. The ex-dividend date is Tuesday, September 30th.

Agilent Technologies has a dividend payout ratio of 16.4% indicating that its dividend is sufficiently covered by earnings. Analysts expect Agilent Technologies to earn $6.08 per share next year, which means the company should continue to be able to cover its $0.99 annual dividend with an expected future payout ratio of 16.3%.

Agilent Technologies Price Performance

Shares of NYSE:A traded down $1.38 during midday trading on Friday, reaching $126.24. 2,844,312 shares of the company's stock traded hands, compared to its average volume of 1,826,968. Agilent Technologies has a 1 year low of $96.43 and a 1 year high of $153.84. The company has a market cap of $35.79 billion, a P/E ratio of 29.63, a PEG ratio of 3.93 and a beta of 1.24. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.71 and a current ratio of 2.25. The company has a fifty day simple moving average of $120.25 and a two-hundred day simple moving average of $115.88.

Agilent Technologies (NYSE:A - Get Free Report) last issued its earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $1.37. The business had revenue of $1.74 billion during the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The company's revenue for the quarter was up 10.1% on a year-over-year basis. During the same period last year, the company earned $1.32 EPS. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. Equities analysts predict that Agilent Technologies will post 5.58 EPS for the current fiscal year.

Analyst Ratings Changes

A has been the topic of several research analyst reports. Leerink Partners lifted their price target on Agilent Technologies to $135.00 and gave the stock a "buy" rating in a research report on Friday, May 30th. Wells Fargo & Company lifted their price target on Agilent Technologies from $140.00 to $150.00 and gave the company an "overweight" rating in a research note on Monday, September 15th. Evercore ISI decreased their target price on Agilent Technologies from $130.00 to $128.00 and set an "in-line" rating on the stock in a research report on Thursday, August 28th. Robert W. Baird upped their price objective on Agilent Technologies from $141.00 to $142.00 and gave the company an "outperform" rating in a research report on Thursday, August 28th. Finally, JPMorgan Chase & Co. reduced their target price on Agilent Technologies from $160.00 to $155.00 and set an "overweight" rating on the stock in a research report on Thursday, May 29th. Six analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $140.08.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.